AVTX vs AZN · P/E 0.0, $51.5M cap vs P/E 28, $288.38B cap
Avalo Therapeutics Inc (AVTX) versus AstraZeneca PLC (AZN) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
AZN does not have a complete income-statement cache yet.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. AZN currently screens at market cap $288.38B and trailing P/E 28.0.
Not investment advice. Open the AVTX and AZN stock pages for the full models.
Not investment advice.